Perspective Therapeutics, Inc. financial data

Symbol
CATX on NYSE
Location
Seattle, WA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 16 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 985% % -28%
Debt-to-equity 20% % 17%
Return On Equity -41% % -55%
Return On Assets -34% % -51%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 113,933,436 shares 54%
Common Stock, Shares, Outstanding 74,337,990 shares 5.2%
Entity Public Float $212,873,547 USD
Common Stock, Value, Issued $74,000 USD 5.7%
Weighted Average Number of Shares Outstanding, Basic 73,813,000 shares 15%
Weighted Average Number of Shares Outstanding, Diluted 73,813,000 shares 15%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $84,215,000 USD 102%
General and Administrative Expense $30,233,000 USD 14%
Operating Income (Loss) $113,564,000 USD -25%
Nonoperating Income (Expense) $9,136,000 USD -13%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $104,428,000 USD -30%
Net Income (Loss) Attributable to Parent $103,121,000 USD -30%
Earnings Per Share, Basic -1.4 USD/shares -14%
Earnings Per Share, Diluted -1.4 USD/shares -14%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $30,629,000 USD -50%
Cash, Cash Equivalents, and Short-term Investments $144,700,000 USD -36%
Accounts Receivable, after Allowance for Credit Loss, Current $6,000 USD -95%
Other Assets, Current $35,000 USD -57%
Assets, Current $148,389,000 USD -36%
Property, Plant and Equipment, Net $76,597,000 USD 34%
Operating Lease, Right-of-Use Asset $1,500,000 USD -32%
Intangible Assets, Net (Excluding Goodwill) $362,000 USD 30%
Goodwill $0 USD -100%
Other Assets, Noncurrent $486,000 USD 20%
Assets $266,972,000 USD -22%
Employee-related Liabilities, Current $7,489,000 USD 37%
Liabilities, Current $28,679,000 USD 57%
Deferred Income Tax Liabilities, Net $1,702,000 USD -32%
Operating Lease, Liability, Noncurrent $1,005,000 USD -30%
Other Liabilities, Noncurrent $386,000 USD 602%
Liabilities $59,941,000 USD 19%
Accumulated Other Comprehensive Income (Loss), Net of Tax $110,000 USD
Retained Earnings (Accumulated Deficit) $334,840,000 USD -45%
Stockholders' Equity Attributable to Parent $207,031,000 USD -29%
Liabilities and Equity $266,972,000 USD -22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $21,582,000 USD -256%
Net Cash Provided by (Used in) Financing Activities $9,973,000 USD -94%
Net Cash Provided by (Used in) Investing Activities $5,565,000 USD 88%
Common Stock, Shares Authorized 750,000,000 shares 0%
Common Stock, Shares, Issued 74,337,990 shares 5.2%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $17,174,000 USD -113%
Deferred Tax Assets, Valuation Allowance $60,364,000 USD 44%
Deferred Tax Assets, Gross $67,737,000 USD 33%
Operating Lease, Liability $1,628,000 USD -32%
Depreciation $346,000 USD 92%
Payments to Acquire Property, Plant, and Equipment $4,656,000 USD -49%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $102,960,000 USD -30%
Lessee, Operating Lease, Liability, to be Paid $1,808,000 USD -33%
Property, Plant and Equipment, Gross $82,801,000 USD 37%
Operating Lease, Liability, Current $623,000 USD -35%
Lessee, Operating Lease, Liability, to be Paid, Year Two $569,000 USD -12%
Lessee, Operating Lease, Liability, to be Paid, Year One $725,000 USD -35%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) $2,097,000 USD 21%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $180,000 USD -42%
Lessee, Operating Lease, Liability, to be Paid, Year Three $514,000 USD 4.3%
Deferred Tax Assets, Operating Loss Carryforwards $31,063,000 USD -12%
Preferred Stock, Shares Authorized 7,000,000 shares 0%
Unrecognized Tax Benefits $1,197,000 USD 128%
Lessee, Operating Lease, Liability, to be Paid, Year Four $443,000 USD 93%
Deferred Tax Assets, Net of Valuation Allowance $7,373,000 USD -18%
Share-based Payment Arrangement, Expense $8,966,000 USD 72%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%